Page 251 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global coronavirus death toll surpasses 2 5 million

Global coronavirus death toll surpasses 2.5 million From CNN s Hamdi Alkhshali Grave diggers push the coffin of a Covid-19 victim before a burial at the Alto de Sao Joao cemetery in Lisbon, Portugal, on February 18. Patricia De Melo Moreira/AFP/Getty Images More than 2.5 million people across the world have died due to coronavirus. At least 2,500,770 people have died since the beginning of the pandemic, according to Johns Hopkins University data. The milestone of 2 million global Covid-19 deaths was recorded on Jan. 15. The US leads with the most deaths followed by Brazil, Mexico, India and the UK. On Feb. 22, the US surpassed the 500,00 total Covid-19 deaths mark, according to Johns Hopkins University.

Alto de sao joaoMinas geraisUnited kingdomNew yorkUnited statesUnited arab emiratesDistrict of columbiaSouth africaMoskovskaya oblastBruxelles capitaleHamdi alkhshaliAmanda wattsSteven ferdman gettyJohnson covidChloe adamsJaide timm garcia

Moderna forecasts $18bn in sales of Covid vaccine this year

Moderna forecasts $18bn in sales of Covid vaccine this year Julia Kollewe © Provided by The Guardian Photograph: Paul Sancya/AP Moderna expects to rake in $18.4bn (£13bn) of sales from its coronavirus vaccine this year, marking a huge turnaround in the fortunes of the US biotech firm. The expected revenue is far higher than the $11.2bn predicted by analysts, and exceeds the $15bn in sales that its US rival Pfizer expects for the Covid-19 vaccine that it developed with Germany’s BioNTech. Massachusetts-based Moderna, founded 11 years ago, said the final number could even exceed the $18.4bn its current deals would bring in, as it was in discussions with several governments about further orders. It is also in talks with Covax, a mechanism created to distribute Covid vaccine doses fairly around the world.

South africaUnited kingdomSouth koreaDerrick rossiUs national institutes of healthGuardian photographஒன்றுபட்டது கிஂக்டம்தெற்கு கொரியாடெரிக் ரோஸிஎங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்பாதுகாவலர் புகைப்படம்

Moderna COVID vaccine for South Africa variant ready for testing: Company

US firm Moderna said on Wednesday that its new vaccine that targets South African variant of coronavirus is ready for testing. The company said that the doses have been shipped to US National Institutes of Health for testing. South African strain of coronavirus is considered to be more dangerous as it believed to hinder the action of antibodies that target the older strain of the virus.

South africaSouth africanDrug administrationUs national institutes of healthCoronavirus outbreakCoronavirus vaccineSouth africa variantCo vidWorld newsWionews comஎங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்இணை வித்உலகம் செய்தி

Pfizer to test third dose, tweaked vaccine to target variant identified in SA

Pfizer to test third dose, tweaked vaccine to target variant identified in SA
ewn.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ewn.co.za Daily Mail and Mail on Sunday newspapers.

South africaUnited statesUnited kingdomSouth africanAlbert bourlaUs national institutes of healthஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்

5 things you need to know now - Johnson & Johnson COVID-19 vaccine nears approval, Moderna readies booster

Official site of The Week Magazine, offering commentary and analysis of the day s breaking news and current events as well as arts, entertainment, people and gossip, and political cartoons.

South africaDrug administrationUs national institutes of healthAssociated pressFive thingsஎங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்தொடர்புடையது ப்ரெஸ்ஐந்து விஷயங்கள்